Name | Reveromycin A |
---|---|
Synonyms | reveromycin a |
Description | Reveromycin A, a benzoquinoid antibiotic isolated from the genus Streptomyces, is a selective inhibitor of protein synthesis in eukaryotic cells. Reveromycin A inhibits bone resorption by inducing apoptosis specifically in osteoclasts. Reveromycin A has antiproliferative activity against tumor cell lines and antifungal activity[1][2]. |
---|---|
Related Catalog | |
In Vitro | Reveromycin A inhibits protein synthesis in osteoclasts (OCs) by selectively blocking enzymatic activity of isoleucyl-tRNA synthetase[2]. Reveromycin A (0.3-30 μM; for 24 h) induces apoptosis in OCs through inhibition of protein synthesis[2]. |
In Vivo | Reveromycin A (20 mg/kg; twice daily; i.v.; for 3 days) significantly decreases numbers of OCs without affecting numbers of osteoblasts in normal 4-week-old male Sprague-Dawley rats[2]. |
References |
Density | 1.21g/cm3 |
---|---|
Boiling Point | 849ºC at 760mmHg |
Molecular Formula | C36H52O11 |
Molecular Weight | 660.79100 |
Flash Point | 258.7ºC |
Exact Mass | 660.35100 |
PSA | 176.89000 |
LogP | 6.13130 |
Vapour Pressure | 0mmHg at 25°C |
Index of Refraction | 1.561 |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
Hazard Codes | Xi |
RIDADR | NONH for all modes of transport |